We intersected our sites with the Editome Disease Knowledgebase [35] and found a study that showed RNA editing at chr5:79923430 is responsible for upregulating dihydrofolate reductase (DHFR) in breast cancer [36]. This evidence concerns the gene DHFR and breast carcinoma.